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Background
Previous studies have showed that the lipokine palmitoleic
acid (or palmitoleate) reduces diet induced muscle and
liver inflammation and insulin resistance [1] and increases
adipose tissue lipolysis, the latter through a mechanism
that depends on PPAR-a [2]. Here we tested whether
palmitoleate protects from the deleterious effects of a high
fat diet (HFD) on glucose homeostasis and liver inflamma-
tion and whether PPAR-a is involved in these actions.
Materials and methods
C57BL (C57) and PPAR-a knockout (KO) mice fed
either with a balanced (BD) or HFD during 12 weeks
were treated after the 10th week with oleic acid (OLA,
300mg/kg of b.w.) or palmitoleate (PMA, 300mg/kg of
b.w.) and evaluated for glucose and insulin tolerances
(GTT and ITT), glucose uptake and metabolism, serum
levels of aspartate aminotransferase (AST) and hepatic
triacylglycerol content and cytokines levels (ELISA) and
gene expression (qRT-PCR).
Results
HFD promotes insulin resistance and hepatic steatosis in
both C57 and KO as evidenced by the reduced (p<0.05)
muscle insulin stimulated glucose uptake and incorpora-
tion and increased (p<0.05) hepatic triacylglycerol content
and plasma AST levels. Surprisingly, the hepatic steatosis
induced by HFD was associated with liver inflammation in
KO, but not C57 mice as shown by the increased (p<0.05)
hepatic levels of IL1-b, IL-12 and TNF-a. In spite of these
genotype specific phenotypes, HFD increased (p<0.05)
TLR4 expression and decreased (p<0.05) the IL1-Ra
expression similarly in both C57 and KO. Independently
of mice genotype, palmitoleate markedly attenuated the
insulin resistance induced by HFD as evidenced by the
improved glucose tolerance and response to insulin in the
ITT (p<0.05) and increased glucose uptake and incorpora-
tion in muscle in vitro (p<0.05). Furthermore, palmitoleate
reduced (p<0.05) the serum levels of AST in C57 and
decreased (p<0.05) the hepatic levels of IL1-b and IL-12 in
KO mice. Finally, palmitoleate reduced the hepatic TLR-4
expression (p<0.05) and increased IL-1Ra expression
(p<0.05) in C57 but not in KO.
Conclusions
We concluded that palmitoleate attenuates diet induced
insulin resistance, hepatic steatosis, inflammation and
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